NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price

NeoGenomics, Inc. (NEO) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $6.11 per share as of 2022-12-31, per its 10-K filed 2023-02-24.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2023-02-24

2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $6.11.
2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $13.93.
2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $6.07.
2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $3.60.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
2022-12-31	$6.11 10-K · filed 2023-02-24
2021-12-31	$13.93 10-K · filed 2023-02-24
2020-12-31	$6.07 10-K · filed 2022-02-25
2019-12-31	$3.60 10-K · filed 2021-02-25
2018-12-31	$2.67 10-K · filed 2020-02-28
2017-12-31	$2.29 10-K · filed 2019-02-26
2016-12-31	$2.09 10-K · filed 2018-03-13
2015-12-31	$2.22 10-K · filed 2017-03-14
2014-12-31	$1.35 10-K · filed 2016-04-18
2013-12-31	$1.02 10-K · filed 2015-03-03
2012-12-31	$0.71 10-K · filed 2014-02-24

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
20/20 Biolabs, Inc. (AIDX)	United States	$0.005B